Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dawn Graham Insider Profile
4 Followers
Dawn Graham, Director at Medivation, holds 25.00K shares in Xenon (Ticker: XENE), holds 15.00K shares in ACELYRIN, INC. (Ticker: SLRN), holds 5.38K shares in Global Blood Therapeutics (Ticker: GBT). Most recently, Dawn Graham Sold ― shares of Xenon on Aug 24, 2023 for an estimated value of 967.50K.
Profitable Transactions
6 out of 12 Profitable Transactions
Average Return
+31.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dawn Graham holds in companies
Most Profitable Insider Trade
The most profitable trade made by Dawn Graham
Dawn Graham's Trading History
Medivation
Sep 30, 2016
―
Uninformative Sell
―
$979.17K
PTC Therapeutics
Jun 10, 2022
Director
Informative Sell
20.07K
$753.57K
Xenon
Aug 24, 2023
Director
Informative Sell
967.50K
$1.00M
Endocyte
Dec 21, 2018
―
Uninformative Sell
90.00K
$0.00
Global Blood Therapeutics
Jun 22, 2022
―
Uninformative Sell
51.97K
$368.20K
Adverum Biotechnologies
May 18, 2022
Director
Informative Buy
25.50K
$567.00K
ACELYRIN, INC.
May 11, 2023
Director
Informative Buy
270.00K
$72.30K
List of latest transactions for each holding click on a transaction to see Dawn Graham's performance on stock
You May Also Like
Dawn Graham insider profile FAQ
What is the percentage of profitable transactions made by Dawn Graham?
The percentage of profitable transactions made by Dawn Graham is 50%.
What is the average return per transaction made by Dawn Graham?
The average return per transaction made by Dawn Graham is 31.60%.
What stocks does Dawn Graham hold?
Dawn Graham holds: MDVN, PTCT, XENE, ECYT, GBT, ADVM, SLRN stocks.
What was Dawn Graham’s latest transaction?
Dawn Graham latest transaction was an Informative Sell of $967.50K.
What was Dawn Graham's most profitable transaction?
Dawn Graham’s most profitable transaction was an Informative Buy of XENE stock on August 15, 2017. The return on the trade was 377.50%.
What is Dawn Graham's role in Medivation?
Dawn Graham's role in Medivation is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.